Historical Archive

Tuscany. Discounted prices for life-saving drugs. Pass a motion by Romanelli (SEL)

The Conference of the Regions will deal with the subject by the hour: Enrico Rossi announced it in the classroom

“It is unacceptable that in Italy today there are paid life-saving drugs. They are cancer drugs or new HIV or diabetes drugs, meningococcal vaccines or chronic kidney disease remedies. Unfortunately it is a legacy of the Monti government. The Balduzzi decree of November 2012 perhaps wanted to bridge the gap between European registration and marketing in Italy, but in fact it created a social inequality, given that the high cost of these drugs means that many citizens cannot use them".

With these words, councilor Mauro Romanelli, from the Mixed group, presented the motion on life-saving drugs signed by representatives of all the groups present in the Regional Council. “We wonder why this flaw has not yet been remedied,” asked Romanelli as the first signatory. “We ask the Junta to urge the Government to resolve the problem quickly. These drugs must be available immediately at a discounted price.

Romanelli (SEL): "Satisfaction with the unanimous vote and commitment of President Rossi"

A motion was unanimously approved today in the Regional Council of Tuscany, first signatory Mauro Romanelli of Sinistra Ecologia e Libertà, on the matter of paid life-saving drugs.
"I am satisfied that on this matter, reported by many citizens, there was the unanimous attention of the entire Regional Council: in Italy there is too long a time gap between when an innovative drug is registered at European level and its placing on the market". "And the initiative of the Monti government to allow these medicines to be present in pharmacies in the meantime without reimbursement from the National Health System, although probably animated by good intentions, has created a hateful discrimination between rich citizens and those who cannot

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco